Prostate Cancer

Study Compares Surgery, Radiation, and Active Monitoring to Treat Prostate Cancer

A study of men in the United Kingdom with early-stage prostate cancer found they were just as likely to survive 10 years whether they had surgery, radiation, or active monitoring – which meant closely watching their disease for any changes and giving them active treatment only if needed.

How Family History Affects Prostate Cancer Risk

It has long been known that men with a family history of prostate cancer are at higher risk of getting it themselves. Now researchers from Sweden have calculated just how much having a brother or father with prostate cancer – or both – raises the risk.

ACS Report: Number of US Cancer Survivors Expected to Exceed 20 Million by 2026

A new report by the American Cancer Society – in collaboration with the National Cancer Institute – estimates there are more than 15.5 million cancer survivors alive in the US today, and that number will grow to more than 20 million by 2026.

4 Cancer Screening Tests for Men

Celebrate the fathers in your life this June by encouraging them to protect their health by getting up to date on cancer screening tests.

Annual Report to the Nation: Cancer Death Rates Still Dropping

The death rate from cancer in the United States is continuing the decline that began in the early 1990s, according to the latest Annual Report to the Nation on the Status of Cancer.

World Health Organization Says Processed Meat Causes Cancer

The International Agency for Research on Cancer (IARC) has classified processed meat as a carcinogen, something that causes cancer.

Obesity Linked to Prostate Cancer in Black Men

A study by researchers in Seattle and their colleagues has found that obesity is linked to a significantly increased risk of prostate cancer in black men.

Study: Targeted Biopsy Improves Accuracy of Prostate Cancer Diagnoses

Researchers from the National Cancer Institute have found that using a type of targeted biopsy finds more high-risk prostate cancers and fewer low-risk prostate cancers than standard biopsy.

Ovarian and Prostate Cancers: What to Ask the Doctor at a Routine Visit

September is both National Ovarian Cancer Awareness Month and National Prostate Cancer Awareness Month. It’s a good time to remember to ask your doctor about specific symptoms that could be linked to these cancers.

Long-term Care Guidelines for Prostate Cancer Survivors

An estimated 2.8 million men in the United States are living with prostate cancer or have had it at one time, and that number is growing.

Study: Cialis (Tadalafil) Does Not Prevent Erectile Dysfunction in Prostate Cancer Patients

Researchers from the Mayo Clinic and colleagues across the United States and Canada have found that Cialis (tadalafil) does not help men avoid erectile dysfunction after radiation therapy for prostate cancer.

Volunteers: Motivated to Help Others

Many cancer survivors are moved by their own experience to help others facing diagnosis and treatment. Find inspiration and hope in these stories of volunteers who are making a difference in the fight against cancer.

Gene Test Shows Promise for Identifying Aggressive Prostate Cancer

Researchers from Columbia University have identified 3 genes they used to predict whether prostate cancer in men with low-risk disease would stay low-risk, or become more of a threat.

Living with Prostate Cancer

If you’re living with prostate cancer, you may be able to live longer and healthier by making some changes to your eating and exercise routine.

Omega-3 Fatty Acids Linked to Increase in Prostate Cancer Risk

A study conducted by researchers at cancer centers across the US has found a link between omega-3 fatty acids and an increased risk of prostate cancer.

FDA Approves Xofigo for Advanced Prostate Cancer

The US Food and Drug Administration (FDA) has approved Xofigo (radium-223 dichloride) to treat certain men with advanced prostate cancer.

Doctors’ Associations Release New Recommendations for Prostate Cancer Screening

Two physicians’ groups are recommending informed decision-making for screening for prostate cancer. This is in line with American Cancer Society guidelines for early detection of prostate cancer.

Study Confirms Long-Term Side Effects from Prostate Cancer Treatment

A new study has found that 15 years after treatment with surgery or radiation, most prostate cancer patients have sexual side effects, and many also have urinary and bowel problems.

Report Studies Link between World Trade Center Exposure and Cancer Risk

A study of people exposed to Ground Zero has found that early responders and recovery workers at site of the World Trade Center terrorist attack do not appear to have an increased risk of cancer overall thus far.

Understanding Hormone Therapy

Hormone therapies work with the natural properties of these substances to relieve symptoms and even fight diseases, including cancer.

Prostate Cancer Screening FAQ

Screening – or testing to find a disease in people without symptoms – can help find some types of cancer early, when it’s more easily treated.

Study: New Drug Enzalutamide Extends Life in Advanced Prostate Cancer

A clinical trial of the new drug enzalutamide (formerly called MDV3100) has shown it extends life by an average of 5 months in the most advanced stages of prostate cancer, even after other treatments.

Study: Surgery No Better Than Observation for Localized Prostate Cancer

A study by researchers from across the U.S. has found that men with localized prostate cancer lived just as long whether or not they had prostate-removal surgery.

Task Force Recommends Against Routine Prostate Cancer Screening

The United States Preventive Services Task Force (USPSTF) has issued new recommendations against prostate cancer screening.

Study Supports Intensity Modulated Radiation Therapy for Prostate Cancer

Researchers have found that intensity modulated radiation therapy is better at controlling localized prostate cancer than conformal radiation therapy and is just as effective as proton therapy.

Study: Dutasteride Helps Men Undergoing Active Surveillance for Prostate Cancer

Researchers in the U.S. and Canada have found that men with low-risk prostate cancer who took the drug dutasteride (Avodart) had lower rates of their cancer worsening than men who didn’t take the drug.

Study: Robotic Surgery Does Not Lessen Common Side Effects from Prostate Removal

A team led by researchers from Massachusetts General Hospital found that men were just as bothered by sexual and urinary side effects when they had robotic prostate surgery as when they had traditional surgery.

Gene Mutation Linked to Hereditary Prostate Cancer

Researchers studying why prostate cancer runs in families have found a genetic mutation that may begin to answer that question.